Clinical Trial Update: Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection [Phase 1, Phase 2]

View source ↗

Summary

Berinert (C1 esterase inhibitor) was studied in Phase 1/2 trials to prevent rejection in kidney transplant recipients. The update reports on safety and tolerabi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection
• Kidney Transplantation

Drugs mentioned

• Berinert (C1 esterase inhibitor)

Snippet

Sponsor: Stanley Jordan, MD | Conditions: Kidney Transplantation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-08-03